Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Downgrade	Alcon downgraded to Sell from Neutral at Citi » 06:24 07/06/20 07/06 06:24 07/06/20 06:24 ALC Alcon $58.76 / +0.32 (+0.55%) Citi analyst Joanne… Citi analyst Joanne Wuensch downgraded Alcon to Sell from Neutral with an unchanged price target of $55. With COVID-19, Alcon "bore the brunt" of not only lower surgical sales as cataract surgery came to a near standstill in the beginning of Q2, but also vision care sales with fewer patient visits in the ophthalmologist office, Wuensch tells investors in a research note. The analyst believes a potential recovery is now fully valued into Alcon shares. ShowHide Related Items >><< Company News Street Research Earnings ALC Alcon $58.76 / +0.32 (+0.55%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $58.76 / +0.32 (+0.55%) 06/16/20 Guggenheim Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown 06/16/20 Guggenheim Alcon upgraded to Buy from Neutral at Guggenheim 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan ALC Alcon $58.76 / +0.32 (+0.55%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c

Over a week ago
Conference/Events	Alcon management to meet with Morgan Stanley » 09:25 06/23/20 06/23 09:25 06/23/20 09:25 ALC Alcon $60.76 / -0.19 (-0.31%) Medical Technology… Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley. ShowHide Related Items >><< Company News Street Research Earnings Events ALC Alcon $60.76 / -0.19 (-0.31%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $60.76 / -0.19 (-0.31%) 06/16/20 Guggenheim Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown 06/16/20 Guggenheim Alcon upgraded to Buy from Neutral at Guggenheim 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan ALC Alcon $60.76 / -0.19 (-0.31%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c 06/23/20 Alcon - ALC
Conference/Events	Alcon management to meet with Morgan Stanley » 04:55 06/23/20 06/23 04:55 06/23/20 04:55 ALC Alcon $60.76 / -0.19 (-0.31%) Medical Technology… Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley. ShowHide Related Items >><< Company News Street Research Earnings Events ALC Alcon $60.76 / -0.19 (-0.31%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $60.76 / -0.19 (-0.31%) 06/16/20 Guggenheim Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown 06/16/20 Guggenheim Alcon upgraded to Buy from Neutral at Guggenheim 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan ALC Alcon $60.76 / -0.19 (-0.31%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c 06/23/20 Alcon - ALC
Conference/Events	Alcon management to meet with Morgan Stanley » 16:25 06/22/20 06/22 16:25 06/22/20 16:25 ALC Alcon $60.76 / -0.19 (-0.31%) Medical Technology… Medical Technology Analyst Lewis holds a conference call with CEO Endicott on June 23 at 10 am hosted by Morgan Stanley. ShowHide Related Items >><< Company News Street Research Earnings ALC Alcon $60.76 / -0.19 (-0.31%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $60.76 / -0.19 (-0.31%) 06/16/20 Guggenheim Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown 06/16/20 Guggenheim Alcon upgraded to Buy from Neutral at Guggenheim 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan ALC Alcon $60.76 / -0.19 (-0.31%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c
Upgrade	Guggenheim upgrades Alcon to Buy on strong momentum exiting shutdown » 07:08 06/16/20 06/16 07:08 06/16/20 07:08 ALC Alcon $57.97 / +0.385 (+0.67%) , NVS Novartis $85.17 / +0.81 (+0.96%) As previously reported,… As previously reported, Guggenheim analyst Chris Pasquale upgraded Alcon (ALC) to Buy from Neutral with a $68 price target. Over the last 14 months, since Alcon's spinoff from Novartis (NVS), the stock's premium has "nearly been cut in half," but his own optimism about the company's long-term growth potential has not changed, Pasquale tells investors. He sees strong momentum in its key segments, is encouraged by early signs of a rebound in eye care volumes, and contends consensus estimates for 2021 "have overshot to the downside," the analyst added. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVS ALC NVS Novartis $85.17 / +0.81 (+0.96%) 06/15/20 FDA revokes emergency use authorization for hydroxychloroquine for COVID-19 06/10/20 51 attorneys general file antitrust lawsuit against generic drug makers 06/05/20 Oxford study shows hydroxychloroquine had no benefit in COVID-19 patients 06/02/20 Novartis reports FDA has extended review of sBLA for ofatumumab ALC Alcon $57.97 / +0.385 (+0.67%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC NVS ALC Alcon $57.97 / +0.385 (+0.67%) 06/16/20 Guggenheim Alcon upgraded to Buy from Neutral at Guggenheim 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS NVS Novartis $85.17 / +0.81 (+0.96%) 06/15/20 Fly Intel: Top five analyst upgrades 06/15/20 Citi Novartis upgraded to Buy from Neutral at Citi 06/03/20 H.C. Wainwright H.C. Wainwright reiterates Buy on Genmab, says ofatumumab delay not impactful 05/18/20 Jefferies Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas NVS ALC NVS Novartis $85.17 / +0.81 (+0.96%) 04/28/20 Novartis sees FY20 revenue to grow mid to high-single digit 04/28/20 Novartis reports Q1 EPS $1.56, consensus $1.36 01/09/20 Cryoport sees FY19 revenue approximately $33.9M, consensus $35.11M ALC Alcon $57.97 / +0.385 (+0.67%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c NVS NVS Novartis $85.17 / +0.81 (+0.96%) 06/03/20 Antidepressant Zoloft APIs are scarce amid COVID-19, FiercePharma says 05/25/20 WHO's hydroxychloroquine trial suspended pending safety data, Bloomberg says 05/22/20 Hydroxychloroquine linked to higher death risk in COVID patients, WaPo reports 05/18/20 Trump taking hydroxychloroquine to prevent coronavirus infection, CNBC says NVS NVS Novartis $85.17 / +0.81 (+0.96%) 05/23/20 Week in Review: How Trump's policies moved stocks 04/25/20 Week in Review: How Trump's policies moved stocks 02/25/20 Tesla, Nvidia downgrades, Regeneron upgrades among today's top analyst calls 02/25/20 Jefferies says buy Regeneron following Novartis' new eye drug safety issue NVS NVS Novartis $85.17 / +0.81 (+0.96%) 03/06/20 Largest borrow rate increases among liquid names 03/03/20 Largest borrow rate increases among liquid names

Upgrade	Alcon upgraded to Buy from Neutral at Guggenheim » 06:06 06/16/20 06/16 06:06 06/16/20 06:06 ALC Alcon $57.97 / +0.385 (+0.67%) Guggenheim upgraded Alcon… Guggenheim upgraded Alcon to Buy from Neutral. ShowHide Related Items >><< Company News Street Research Earnings ALC Alcon $57.97 / +0.385 (+0.67%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $57.97 / +0.385 (+0.67%) 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS 05/14/20 Stephens Alcon upgraded to Overweight on quicker bounce back potential at Stephens ALC Alcon $57.97 / +0.385 (+0.67%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c
Conference/Events	Alcon management to meet virtually with BTIG » 04:55 06/15/20 06/15 04:55 06/15/20 04:55 ALC Alcon $57.58 / -0.4 (-0.69%) Virtual Meeting to be… Virtual Meeting to be held on June 15 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Events ALC Alcon $57.58 / -0.4 (-0.69%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $57.58 / -0.4 (-0.69%) 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS 05/14/20 Stephens Alcon upgraded to Overweight on quicker bounce back potential at Stephens ALC Alcon $57.58 / -0.4 (-0.69%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c 06/15/20 Alcon
Conference/Events	Alcon management to meet virtually with BTIG » 11:54 06/12/20 06/12 11:54 06/12/20 11:54 ALC Alcon $57.85 / -0.13 (-0.22%) Virtual Meeting to be… Virtual Meeting to be held on June 15 hosted by BTIG. ShowHide Related Items >><< Company News Street Research Earnings Events ALC Alcon $57.85 / -0.13 (-0.22%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval ALC Alcon $57.85 / -0.13 (-0.22%) 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS 05/14/20 Stephens Alcon upgraded to Overweight on quicker bounce back potential at Stephens ALC Alcon $57.85 / -0.13 (-0.22%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c 06/15/20 Alcon
Conference/Events	Goldman Sachs to hold a virtual conference » 04:55 06/11/20 06/11 04:55 06/11/20 04:55 CERN Cerner $71.85 / -0.03 (-0.04%) , INCY Incyte $93.07 / + (+0.00%) , ALC Alcon $61.28 / -0.22 (-0.36%) , MDT Medtronic $97.57 / -1.44 (-1.45%) , RHHBY Roche $0.00 / + (+0.00%) , FMS Fresenius Medical $43.62 / +0.18 (+0.41%) , IVBXF Innovent Biologics $0.00 / + (+0.00%) , QURE uniQure $63.09 / -0.08 (-0.13%) , SWTX SpringsWorks Therapeutics $45.20 / +2.21 (+5.14%) 41st Annual Global… 41st Annual Global Healthcare Virtual Conference will be held on June 9-11. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWTX RHHBY QURE MDT INCY FMS CERN ALC SWTX SpringsWorks Therapeutics $45.20 / +2.21 (+5.14%) 05/12/20 SpringsWorks Therapeutics says COVID-19 has had 'relatively modest impact' 03/18/20 SpringsWorks Therapeutics granted new patent by USPTO 02/27/20 MapKure, SpringsWorks, BeiGene initiate Phase 1 trial of BGB-3245 01/13/20 Allogene, SpringsWorks Therapeutics announce clinical trial collaboration RHHBY Roche $0.00 / + (+0.00%) 06/08/20 Innovent Biologics to partner with Roche on product development 06/04/20 Roche receives EUA for Elecsys IL-6 test 05/29/20 FDA approves Genentech's Tecentriq in combination with Avastin 05/29/20 Ligand announces expansion of Icagen license agreement with Roche QURE uniQure $63.09 / -0.08 (-0.13%) 05/14/20 uniQure presents preclinical data in SCA3, Fabry Disease, Hemophilia A 04/29/20 uniQure expects cash to be sufficient to fund operations into 2022 04/29/20 uniQure continuing work to resume treatment in Phase I/II trial of AMT-130 04/29/20 uniQure on track to provide data from HOPE-B trial before year-end MDT Medtronic $97.57 / -1.44 (-1.45%) 06/09/20 Medtronic to release new data at ADA virtual sessions 06/05/20 Medtronic recieves CE Mark for one-month DAPT indication for Resolute Onyx DES 06/04/20 Titan Medical announces development, license agreements with Medtronic 05/28/20 Medtronic issues 'Class I' recall for HeartWare HVAD pump outflow graft INCY Incyte $93.07 / + (+0.00%) 05/14/20 MorphoSys announces long-term follow-up results from L-MIND study of tafasitamab 05/06/20 Incyte announces FDA accelerated approval of Tabrecta 05/05/20 Incyte backs FY20 Jakafi net product revenues guidance of $1.88B-$1.95B 05/05/20 Incyte reports Q1 Jakafi net product revenue up 22% to $459.48M FMS Fresenius Medical $43.62 / +0.18 (+0.41%) 05/01/20 FDA shares guideline for emergency use of Fresenius system in COVID-19 patients 02/19/20 Fresenius Medical boosts dividend to EUR 1.20 per share CERN Cerner $71.85 / -0.03 (-0.04%) 06/03/20 R1 RCM to acquire Cerner RevWorks, terms not disclosed 06/02/20 Wisconsin Health System chooses Cerner's behavioral health technology 06/01/20 Cerner appoints Jerome Labat as CTO 05/20/20 Cerner, Health IQ partner to support health systems with predictive analytics ALC Alcon $61.28 / -0.22 (-0.36%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval CERN INCY ALC MDT RHHBY FMS IVBXF QURE SWTX CERN Cerner $71.85 / -0.03 (-0.04%) 06/10/20 Lake Street OptimizeRx news strategically significant, broadens reach, says Lake Street 06/09/20 Piper Sandler GAO reports validate Cerner contract with VA, says Piper Sandler 05/01/20 SunTrust Cerner downgraded to Hold from Buy at SunTrust 05/01/20 SunTrust Cerner downgraded to Hold from Buy at SunTrust INCY Incyte $93.07 / + (+0.00%) 06/04/20 Argus Incyte price target raised to $124 from $92 at Argus 05/26/20 Goldman Sachs Incyte downgraded to Buy from Conviction Buy at Goldman Sachs 05/19/20 Cantor Fitzgerald Incyte price target raised to $100 from $83 at Cantor Fitzgerald 05/06/20 Piper Sandler Incyte approval of Tabrecta came soon than expected, says Piper Sandler ALC Alcon $61.28 / -0.22 (-0.36%) 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS 05/14/20 Stephens Alcon upgraded to Overweight on quicker bounce back potential at Stephens MDT Medtronic $97.57 / -1.44 (-1.45%) 05/26/20 SunTrust Medtronic price target lowered to $105 from $130 at SunTrust 05/21/20 Piper Sandler Medtronic price target lowered to $120 from $135 at Piper Sandler 05/21/20 Piper Sandler Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler 05/14/20 DZ Bank Medtronic downgraded to Hold from Buy at DZ Bank RHHBY Roche $0.00 / + (+0.00%) 06/10/20 SunTrust Arcus Biosciences price target raised to $45 from $22 at SunTrust 06/10/20 Morgan Stanley Morgan Stanley calls Merck bladder cancer failure 'marginal perception negative' 05/15/20 Barclays Roche price target raised to CHF 395 from CHF 385 at Barclays 05/14/20 Mizuho Arcus Biosciences price target raised to $40 from $22 at Mizuho FMS Fresenius Medical $43.62 / +0.18 (+0.41%) 06/01/20 Barclays Fresenius Medical price target raised to EUR 88 from EUR 81 at Barclays 05/20/20 Fly Intel: Top five analyst upgrades 05/20/20 Morgan Stanley Fresenius Medical upgraded to Equal Weight from Underweight at Morgan Stanley 05/19/20 JPMorgan Fresenius Medical price target lowered to EUR 84.20 from EUR 90.80 at JPMorgan IVBXF Innovent Biologics $0.00 / + (+0.00%) QURE uniQure $63.09 / -0.08 (-0.13%) 03/26/20 Piper Sandler uniQure trial delay 'comes as no surprise,' says Piper Sandler 01/23/20 Cantor Fitzgerald Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate 12/10/19 Mizuho uniQure price target raised to $90 from $67 at Mizuho 12/09/19 Piper Sandler Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH SWTX SpringsWorks Therapeutics $45.20 / +2.21 (+5.14%) 06/02/20 Citi Ayala Pharmaceuticals initiated with a Buy at Citi 05/05/20 Barclays SpringsWorks Therapeutics initiated with an Overweight at Barclays 03/19/20 H.C. Wainwright SpringsWorks Therapeutics upgraded to Buy from Neutral at H.C. Wainwright 03/04/20 Fly Intel: Top five analyst downgrades SWTX RHHBY QURE MDT INCY FMS CERN ALC SWTX SpringsWorks Therapeutics $45.20 / +2.21 (+5.14%) 05/12/20 SpringsWorks Therapeutics reports Q1 EPS (37c), consensus (37c) 03/12/20 SpringsWorks Therapeutics reports Q4 EPS (39c), consensus (37c) RHHBY Roche $0.00 / + (+0.00%) 04/22/20 Roche confirms outlook for 2020 based on assessment of COVID-19 04/22/20 Roche reports Q1 group sales CHF 15.143B vs. CHF 14.826B last year 01/30/20 Roche reports FY19 core EPS CHF20.16 vs. CHF18.14 last year QURE uniQure $63.09 / -0.08 (-0.13%) 04/29/20 uniQure reports Q1 EPS (63c), consensus (84c) 03/02/20 uniQure had $377.8M cash position as of December 31 MDT Medtronic $97.57 / -1.44 (-1.45%) 05/21/20 Medtronic not providing guidance at this time 05/21/20 Medtronic reports Q4 adjusted EPS 58c, consensus $1.06 02/24/20 IntriCon reports Q4 EPS 8c, consensus (4c) 02/18/20 Medtronic sees Q4 organic revenue growth approximately 4.5%, consensus $8.5B INCY Incyte $93.07 / + (+0.00%) 05/05/20 Incyte reports Q1 adj. EPS ($2.86), may not compare to consensus 61c 05/04/20 Notable companies reporting before tomorrow's open 02/13/20 Incyte reports Q4 EPS 65c, consensus 57c FMS Fresenius Medical $43.62 / +0.18 (+0.41%) 02/19/20 Fresenius Medical affirms mid to high single digit 2020 growth outlook 02/19/20 Fresenius Medical reports Q4 adjusted EPS EUR 1.36 vs. EUR 1.29 last year CERN Cerner $71.85 / -0.03 (-0.04%) 04/28/20 Cerner lowers 2020 adjusted EPS outlook to $2.78-$2.90 from $3.09-$3.19 04/28/20 Cerner sees Q2 adjusted EPS 60c-64c, consensus 74c 04/28/20 Cerner reports Q1 EPS 71c, consensus 70c 04/28/20 Notable companies reporting after market close ALC Alcon $61.28 / -0.22 (-0.36%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c RHHBY MDT CERN RHHBY Roche $0.00 / + (+0.00%) 06/05/20 AstraZeneca cancer drug shows signs of helping in severe COVID-19, Reuters says 05/04/20 Roche CEO to CNBC: 'Very likely' people develop immunity after COVID-19 04/29/20 PTC and Roche trial results could be 'trouble' for Biogen's Spinraza, STAT says 03/26/20 Roche reaches deal with Britain to boost COVID-19 testing, Reuters reports MDT Medtronic $97.57 / -1.44 (-1.45%) 05/16/20 Verizon among stocks splitting difference between yield, safety, Barron's says 04/04/20 J&J, Chevron among names with safe dividends for now, Barron's says 03/07/20 J&J, Amgen among healthy dividend stocks as COVID-19 fears grow, Barron's says 02/27/20 LivaNova buyout gained traction at Medtronic, talks early, Reorg says CERN Cerner $71.85 / -0.03 (-0.04%) 04/07/20 VA to delay Cerner EHR rollout amid pandemic, Healthcare IT News reports 02/11/20 Cerner dropped by one of country's largest health systems, KCBJ reports RHHBY QURE MDT INCY CERN RHHBY Roche $0.00 / + (+0.00%) 06/10/20 Seattle Genetics up, Merck slips after Keytruda fails bladder cancer study goals 06/01/20 Analyst says sell Abbott after stock 'overreacted' to COVID-19 opportunity 05/14/20 Allogene jumps, Compugen plunges following release of cancer meeting abstracts 05/04/20 Fly Intel: Wall Street's top stories for Monday QURE uniQure $63.09 / -0.08 (-0.13%) 03/12/20 Piper sees trial disruption risk, calls out Moderna, Inovio as 'COVID-19 plays' MDT Medtronic $97.57 / -1.44 (-1.45%) 05/21/20 Fly Intel: Pre-market Movers 02/24/20 Fly Insider: Tesla, Netflix among weeks notable insider trades 02/12/20 Fly Intel: Wall Street's top stories for Wednesday 02/12/20 Medtronic slips after insulin pumps recalled over safety risk INCY Incyte $93.07 / + (+0.00%) 04/03/20 Fly Intel: Wall Street's top stories for Friday 04/03/20 Fly Intel: Wall Street's top stories at midday 04/02/20 Fly Intel: After-Hours Movers 01/03/20 Fly Intel: Wall Street's top stories for Friday CERN Cerner $71.85 / -0.03 (-0.04%) 03/10/20 Fly Intel: Wall Street's top stories for Tuesday 06/16/20 ADA Virtual Conference 2020 06/12/20 Medtronic - MDT 06/19/20 PDUFA Date for Tecentriq (Atezolizumab) 08/24/20 PDUFA Date for Risdiplam (RG7916) 11/23/20 PDUFA Date for Xofluza QURE MDT INCY CERN QURE uniQure $63.09 / -0.08 (-0.13%) 01/16/20 uniQure put volume heavy and directionally bearish MDT Medtronic $97.57 / -1.44 (-1.45%) 04/30/20 Medtronic put volume heavy and directionally bearish INCY Incyte $93.07 / + (+0.00%) 02/24/20 Largest borrow rate increases among liquid names 01/14/20 Early notable gainers among liquid option names on January 14th CERN Cerner $71.85 / -0.03 (-0.04%) 02/05/20 Early notable gainers among liquid option names on February 5th
Conference/Events	Goldman Sachs to hold a virtual conference » 04:55 06/10/20 06/10 04:55 06/10/20 04:55 CERN Cerner $71.88 / -1.95 (-2.64%) , INCY Incyte $93.27 / -1.3 (-1.37%) , ALC Alcon $61.50 / -1.465 (-2.33%) , MDT Medtronic $99.01 / -2.17 (-2.14%) , RHHBY Roche $0.00 / + (+0.00%) , FMS Fresenius Medical $43.44 / -0.25 (-0.57%) , IVBXF Innovent Biologics $0.00 / + (+0.00%) , QURE uniQure $63.17 / +1.67 (+2.72%) , SWTX SpringsWorks Therapeutics $42.99 / +3.83 (+9.78%) 41st Annual Global… 41st Annual Global Healthcare Virtual Conference will be held on June 9-11. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SWTX RHHBY QURE MDT INCY FMS CERN ALC SWTX SpringsWorks Therapeutics $42.99 / +3.83 (+9.78%) 05/12/20 SpringsWorks Therapeutics says COVID-19 has had 'relatively modest impact' 03/18/20 SpringsWorks Therapeutics granted new patent by USPTO 02/27/20 MapKure, SpringsWorks, BeiGene initiate Phase 1 trial of BGB-3245 01/13/20 Allogene, SpringsWorks Therapeutics announce clinical trial collaboration RHHBY Roche $0.00 / + (+0.00%) 06/08/20 Innovent Biologics to partner with Roche on product development 06/04/20 Roche receives EUA for Elecsys IL-6 test 05/29/20 FDA approves Genentech's Tecentriq in combination with Avastin 05/29/20 Ligand announces expansion of Icagen license agreement with Roche QURE uniQure $63.17 / +1.67 (+2.72%) 05/14/20 uniQure presents preclinical data in SCA3, Fabry Disease, Hemophilia A 04/29/20 uniQure expects cash to be sufficient to fund operations into 2022 04/29/20 uniQure continuing work to resume treatment in Phase I/II trial of AMT-130 04/29/20 uniQure on track to provide data from HOPE-B trial before year-end MDT Medtronic $99.01 / -2.17 (-2.14%) 06/09/20 Medtronic to release new data at ADA virtual sessions 06/05/20 Medtronic recieves CE Mark for one-month DAPT indication for Resolute Onyx DES 06/04/20 Titan Medical announces development, license agreements with Medtronic 05/28/20 Medtronic issues 'Class I' recall for HeartWare HVAD pump outflow graft INCY Incyte $93.27 / -1.3 (-1.37%) 05/14/20 MorphoSys announces long-term follow-up results from L-MIND study of tafasitamab 05/06/20 Incyte announces FDA accelerated approval of Tabrecta 05/05/20 Incyte backs FY20 Jakafi net product revenues guidance of $1.88B-$1.95B 05/05/20 Incyte reports Q1 Jakafi net product revenue up 22% to $459.48M FMS Fresenius Medical $43.44 / -0.25 (-0.57%) 05/01/20 FDA shares guideline for emergency use of Fresenius system in COVID-19 patients 02/19/20 Fresenius Medical boosts dividend to EUR 1.20 per share CERN Cerner $71.88 / -1.95 (-2.64%) 06/03/20 R1 RCM to acquire Cerner RevWorks, terms not disclosed 06/02/20 Wisconsin Health System chooses Cerner's behavioral health technology 06/01/20 Cerner appoints Jerome Labat as CTO 05/20/20 Cerner, Health IQ partner to support health systems with predictive analytics ALC Alcon $61.50 / -1.465 (-2.33%) 05/15/20 Soros adds TransDigm stake, boosts Peloton position, exits Mondelez 05/12/20 Alcon cannot provide FY20 guidance due to COVID-19 04/07/20 Alcon delays initiation of dividend proposal to 2021 to preserve cash 03/02/20 Alcon PMA supplement granted FDA approval CERN INCY ALC MDT RHHBY FMS IVBXF QURE SWTX CERN Cerner $71.88 / -1.95 (-2.64%) 06/09/20 Piper Sandler GAO reports validate Cerner contract with VA, says Piper Sandler 05/01/20 SunTrust Cerner downgraded to Hold from Buy at SunTrust 05/01/20 SunTrust Cerner downgraded to Hold from Buy at SunTrust 04/22/20 Fly Intel: Top five analyst upgrades INCY Incyte $93.27 / -1.3 (-1.37%) 06/04/20 Argus Incyte price target raised to $124 from $92 at Argus 05/26/20 Goldman Sachs Incyte downgraded to Buy from Conviction Buy at Goldman Sachs 05/19/20 Cantor Fitzgerald Incyte price target raised to $100 from $83 at Cantor Fitzgerald 05/06/20 Piper Sandler Incyte approval of Tabrecta came soon than expected, says Piper Sandler ALC Alcon $61.50 / -1.465 (-2.33%) 06/05/20 UBS UBS backs Buy on Alcon after Cooper results 05/21/20 JPMorgan Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan 05/14/20 UBS Alcon price target raised to CHF 65 from CHF 60 at UBS 05/14/20 Stephens Alcon upgraded to Overweight on quicker bounce back potential at Stephens MDT Medtronic $99.01 / -2.17 (-2.14%) 05/26/20 SunTrust Medtronic price target lowered to $105 from $130 at SunTrust 05/21/20 Piper Sandler Medtronic price target lowered to $120 from $135 at Piper Sandler 05/21/20 Piper Sandler Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler 05/14/20 DZ Bank Medtronic downgraded to Hold from Buy at DZ Bank RHHBY Roche $0.00 / + (+0.00%) 05/15/20 Barclays Roche price target raised to CHF 395 from CHF 385 at Barclays 05/14/20 Mizuho Arcus Biosciences price target raised to $40 from $22 at Mizuho 05/13/20 Wolfe Research Roche upgraded to Outperform from Peer Perform at Wolfe Research 05/13/20 Wolfe Research Roche upgraded to Outperform from Peer Perform at Wolfe Research FMS Fresenius Medical $43.44 / -0.25 (-0.57%) 06/01/20 Barclays Fresenius Medical price target raised to EUR 88 from EUR 81 at Barclays 05/20/20 Fly Intel: Top five analyst upgrades 05/20/20 Morgan Stanley Fresenius Medical upgraded to Equal Weight from Underweight at Morgan Stanley 05/19/20 JPMorgan Fresenius Medical price target lowered to EUR 84.20 from EUR 90.80 at JPMorgan IVBXF Innovent Biologics $0.00 / + (+0.00%) QURE uniQure $63.17 / +1.67 (+2.72%) 03/26/20 Piper Sandler uniQure trial delay 'comes as no surprise,' says Piper Sandler 01/23/20 Cantor Fitzgerald Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate 12/10/19 Mizuho uniQure price target raised to $90 from $67 at Mizuho 12/09/19 Piper Sandler Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH SWTX SpringsWorks Therapeutics $42.99 / +3.83 (+9.78%) 06/02/20 Citi Ayala Pharmaceuticals initiated with a Buy at Citi 05/05/20 Barclays SpringsWorks Therapeutics initiated with an Overweight at Barclays 03/19/20 H.C. Wainwright SpringsWorks Therapeutics upgraded to Buy from Neutral at H.C. Wainwright 03/04/20 Fly Intel: Top five analyst downgrades SWTX RHHBY QURE MDT INCY FMS CERN ALC SWTX SpringsWorks Therapeutics $42.99 / +3.83 (+9.78%) 05/12/20 SpringsWorks Therapeutics reports Q1 EPS (37c), consensus (37c) 03/12/20 SpringsWorks Therapeutics reports Q4 EPS (39c), consensus (37c) RHHBY Roche $0.00 / + (+0.00%) 04/22/20 Roche confirms outlook for 2020 based on assessment of COVID-19 04/22/20 Roche reports Q1 group sales CHF 15.143B vs. CHF 14.826B last year 01/30/20 Roche reports FY19 core EPS CHF20.16 vs. CHF18.14 last year QURE uniQure $63.17 / +1.67 (+2.72%) 04/29/20 uniQure reports Q1 EPS (63c), consensus (84c) 03/02/20 uniQure had $377.8M cash position as of December 31 MDT Medtronic $99.01 / -2.17 (-2.14%) 05/21/20 Medtronic not providing guidance at this time 05/21/20 Medtronic reports Q4 adjusted EPS 58c, consensus $1.06 02/24/20 IntriCon reports Q4 EPS 8c, consensus (4c) 02/18/20 Medtronic sees Q4 organic revenue growth approximately 4.5%, consensus $8.5B INCY Incyte $93.27 / -1.3 (-1.37%) 05/05/20 Incyte reports Q1 adj. EPS ($2.86), may not compare to consensus 61c 05/04/20 Notable companies reporting before tomorrow's open 02/13/20 Incyte reports Q4 EPS 65c, consensus 57c FMS Fresenius Medical $43.44 / -0.25 (-0.57%) 02/19/20 Fresenius Medical affirms mid to high single digit 2020 growth outlook 02/19/20 Fresenius Medical reports Q4 adjusted EPS EUR 1.36 vs. EUR 1.29 last year CERN Cerner $71.88 / -1.95 (-2.64%) 04/28/20 Cerner lowers 2020 adjusted EPS outlook to $2.78-$2.90 from $3.09-$3.19 04/28/20 Cerner sees Q2 adjusted EPS 60c-64c, consensus 74c 04/28/20 Cerner reports Q1 EPS 71c, consensus 70c 04/28/20 Notable companies reporting after market close ALC Alcon $61.50 / -1.465 (-2.33%) 05/12/20 Alcon reports Q1 EPS 45c, consensus 35c 04/07/20 Alcon withdraws 2020 guidance on COVID-19 financial impact 02/25/20 Alcon sees FY20 core EPS $1.95-$2.05, consensus $2.01 02/25/20 Alcon reports Q4 core EPS 45c, consensus 46c RHHBY MDT CERN RHHBY Roche $0.00 / + (+0.00%) 06/05/20 AstraZeneca cancer drug shows signs of helping in severe COVID-19, Reuters says 05/04/20 Roche CEO to CNBC: 'Very likely' people develop immunity after COVID-19 04/29/20 PTC and Roche trial results could be 'trouble' for Biogen's Spinraza, STAT says 03/26/20 Roche reaches deal with Britain to boost COVID-19 testing, Reuters reports MDT Medtronic $99.01 / -2.17 (-2.14%) 05/16/20 Verizon among stocks splitting difference between yield, safety, Barron's says 04/04/20 J&J, Chevron among names with safe dividends for now, Barron's says 03/07/20 J&J, Amgen among healthy dividend stocks as COVID-19 fears grow, Barron's says 02/27/20 LivaNova buyout gained traction at Medtronic, talks early, Reorg says CERN Cerner $71.88 / -1.95 (-2.64%) 04/07/20 VA to delay Cerner EHR rollout amid pandemic, Healthcare IT News reports 02/11/20 Cerner dropped by one of country's largest health systems, KCBJ reports RHHBY QURE MDT INCY CERN RHHBY Roche $0.00 / + (+0.00%) 06/01/20 Analyst says sell Abbott after stock 'overreacted' to COVID-19 opportunity 05/14/20 Allogene jumps, Compugen plunges following release of cancer meeting abstracts 05/04/20 Fly Intel: Wall Street's top stories for Monday 05/04/20 Fly Intel: Wall Street's top stories at midday QURE uniQure $63.17 / +1.67 (+2.72%) 03/12/20 Piper sees trial disruption risk, calls out Moderna, Inovio as 'COVID-19 plays' MDT Medtronic $99.01 / -2.17 (-2.14%) 05/21/20 Fly Intel: Pre-market Movers 02/24/20 Fly Insider: Tesla, Netflix among weeks notable insider trades 02/12/20 Fly Intel: Wall Street's top stories for Wednesday 02/12/20 Medtronic slips after insulin pumps recalled over safety risk INCY Incyte $93.27 / -1.3 (-1.37%) 04/03/20 Fly Intel: Wall Street's top stories for Friday 04/03/20 Fly Intel: Wall Street's top stories at midday 04/02/20 Fly Intel: After-Hours Movers 01/03/20 Fly Intel: Wall Street's top stories for Friday CERN Cerner $71.88 / -1.95 (-2.64%) 03/10/20 Fly Intel: Wall Street's top stories for Tuesday 06/16/20 ADA Virtual Conference 2020 06/19/20 PDUFA Date for Tecentriq (Atezolizumab) 08/24/20 PDUFA Date for Risdiplam (RG7916) 11/23/20 PDUFA Date for Xofluza QURE MDT INCY CERN QURE uniQure $63.17 / +1.67 (+2.72%) 01/16/20 uniQure put volume heavy and directionally bearish MDT Medtronic $99.01 / -2.17 (-2.14%) 04/30/20 Medtronic put volume heavy and directionally bearish INCY Incyte $93.27 / -1.3 (-1.37%) 02/24/20 Largest borrow rate increases among liquid names 01/14/20 Early notable gainers among liquid option names on January 14th CERN Cerner $71.88 / -1.95 (-2.64%) 02/05/20 Early notable gainers among liquid option names on February 5th

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial